Cybin CEO AMA: Patents, DMT Trials, Timelines and Raising Capital in a Recession | CYBN Stock

New CAR T-cell therapy shows promise against aggressive HER2+ breast cancer

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast cancer with a poorer prognosis. Investigators of the

November 19, 2024

Backed by Mayo Clinic and Microsoft, a nonprofit forms to test AI tools used in health care

A group of academic hospitals and technology companies will form a new nonprofit venture to oversee a nationwide network of laboratories to test artificial intelligence

January 8, 2024

LEO Pharma’s eczema cream gains MHRA marketing authorisation

Anzupgo (delgocitinib) 20mg/g cream is intended to treat moderate to severe chronic hand eczema in adults. Credit: Kmpzzz/Shutterstock. Leo Pharma has gained marketing authorisation from

December 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.